Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 2, Issue 3
August 2025
In Progress
Blood Neoplasia Cover Image for Volume 2, Issue 3

Volume 2 Issue 3 | Blood Neoplasia | American Society of Hematology

CLINICAL TRIALS AND OBSERVATIONS

Clarithromycin, ixazomib, pomalidomide, dexamethasone for relapsed/refractory myeloma: survival and correlative analysis
Clinical Trials & Observations
Aaron S. Rosenberg,Emanual Maverakis,Caitlin Costello,Elizabeth A. Brem,Matthew Joseph Wieduwilt,Guillaume Luxardi,Paul Kaesberg,Keon Abedi,Samantha Herbert,Joseph Tuscano
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

MYELOID NEOPLASIA

Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasm
Suravi Raychaudhuri,Ted A. Gooley,Allegra Rasmussen,Kim Quach,Eva Gill,Anna B. Halpern,Jacob S. Appelbaum,Cristina M. Ghiuzeli,Paul C. Hendrie,Ryan D. Cassaday,Roland B. Walter,Mary-Elizabeth M. Percival
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
TYK2 is essential for the therapeutic effect of IFN-α in Jak2V617F-induced murine myeloproliferative neoplasms
Yuki Tahira,Kotaro Shide,Takuro Kameda,Taisuke Uchida,Ayako Kamiunten,Keiichi Akizuki,Yoko Kubuki,Masayoshi Karasawa,Ryoma Ikeda,Kengo Matsumoto,Jie Bai,Minoru Terashima,Koji Kato,Tomofumi Uto,Tomohiro Fukaya,Shuya Mitoma,Katsuaki Sato,Yudai Uehira,Hiroaki Ueno,Goro Sashida,Hideki Yamaguchi,Kazuya Shimoda
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

Lymphoid Neoplasia

Tumor-associated myeloid cells support murine T-ALL in the central nervous system via integrin signaling
Ryan S. Humphrey,Seohee Nam,Dennis C. Wylie,Lauren I. R. Ehrlich
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

RESEARCH LETTER

Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab
Charles Pei,Zeinab El Boghdadly,Lisa Blackburn,Nidhi Sharma,Naresh Bumma,Abdullah M. Khan,Srinivas Devarakonda,Elvira Umyarova,Don Benson,Ashley Rosko,Francesca Cottini
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
All Issues

Advertisement intended for health care professionals

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 

Advertisement intended for health care professionals

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals